|
US6858390B2
(en)
|
1998-12-31 |
2005-02-22 |
Ingeneus Corporation |
Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes
|
|
US6403313B1
(en)
*
|
1999-12-21 |
2002-06-11 |
Ingeneus Corporation |
Fluorescent intensity assay for duplex and triplex nucleic acid hybridization solution utilizing fluorescent intercalators
|
|
US6656692B2
(en)
|
1999-12-21 |
2003-12-02 |
Ingeneus Corporation |
Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes
|
|
US6420115B1
(en)
*
|
1999-12-21 |
2002-07-16 |
Ingeneus Corporation |
Cation mediated triplex hybridization assay
|
|
US6924108B2
(en)
|
1999-12-21 |
2005-08-02 |
Ingeneus Corporation |
Nucleic acid binding enhancement by conjugation with nucleotides, nucleosides, bases and/or their analogues
|
|
US6911536B1
(en)
|
1999-12-21 |
2005-06-28 |
Ingeneus Corporation |
Triplex and quadruplex catalytic hybridization
|
|
US7309569B2
(en)
|
1999-12-21 |
2007-12-18 |
Ingeneus, Inc. |
Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes
|
|
US20030181412A1
(en)
*
|
1999-12-21 |
2003-09-25 |
Ingeneus Corporation |
Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses
|
|
US7052844B2
(en)
*
|
1999-12-21 |
2006-05-30 |
Ingeneus, Inc. |
Purification of DS-DNA using heteropolymeric capture probes and a triplex, quadruplex or homologous duplex binding mechanism
|
|
US6927027B2
(en)
|
1999-12-21 |
2005-08-09 |
Ingeneus Corporation |
Nucleic acid multiplex formation
|
|
US20030170659A1
(en)
*
|
2000-01-24 |
2003-09-11 |
Ingeneus Corporation |
Electrical treatment of binding media to encourage, discourage and/or study biopolymer binding
|
|
US6613524B1
(en)
|
2000-01-24 |
2003-09-02 |
Ingeneus Corporation |
Amperometric affinity assay and electrically stimulated complexes of nucleic acids
|
|
US6982147B2
(en)
*
|
2000-01-24 |
2006-01-03 |
Ingeneus Corporation |
Apparatus for assaying biopolymer binding by means of multiple measurements under varied conditions
|
|
US7220541B2
(en)
|
2000-01-24 |
2007-05-22 |
Ingeneus, Inc. |
Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions
|
|
WO2001098537A2
(en)
*
|
2000-06-17 |
2001-12-27 |
Third Wave Technologies, Inc. |
Nucleic acid accessible hybridization sites
|
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
|
WO2002018656A2
(en)
*
|
2000-08-30 |
2002-03-07 |
Avi Biopharma, Inc. |
Method for analysis of oligonucleotide analogs
|
|
EP1326892A2
(en)
|
2000-10-12 |
2003-07-16 |
University of Rochester |
Compositions that inhibit proliferation of cancer cells
|
|
DE10155031A1
(de)
*
|
2001-11-09 |
2003-05-28 |
Friz Biochem Gmbh |
Fluoreszenz-Quenchen zur Detektion von Ligat-Ligand Assoziationsereignissen in elektrischen Feldern
|
|
WO2003065997A2
(en)
|
2002-02-06 |
2003-08-14 |
Vicor Technologies, Inc. |
Anti-infarction molecules
|
|
AU2003253580A1
(en)
*
|
2002-02-26 |
2003-11-17 |
University Of Minnesota |
Variants of nedd4l associated with hypertension and viral budding
|
|
EP1575992A4
(en)
|
2002-08-05 |
2007-02-21 |
Univ Rochester |
CHEMICAL PROTEINS FROM PROTEIN TRANSDUCATING DOMAIN / DEAMINASE, RELATED COMPOUNDS AND THEIR USES
|
|
US20040180345A1
(en)
*
|
2003-03-14 |
2004-09-16 |
Ingeneus Corporation |
Pre-incubation method to improve signal/noise ratio of nucleic acid assays
|
|
WO2005056827A1
(en)
*
|
2003-12-12 |
2005-06-23 |
Infectio Recherche Inc. |
System for charge-based detection of nucleic acids
|
|
US8029815B2
(en)
*
|
2004-04-28 |
2011-10-04 |
Elford Howard L |
Methods for treating or preventing restenosis and other vascular proliferative disorders
|
|
NZ554538A
(en)
*
|
2004-09-24 |
2009-12-24 |
Ingeneus Inc |
Genomic assay
|
|
JP5225069B2
(ja)
|
2005-03-23 |
2013-07-03 |
ゲンマブ エー／エス |
多発性骨髄腫の治療のためのｃｄ３８に対する抗体
|
|
US7476733B2
(en)
*
|
2005-03-25 |
2009-01-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease
|
|
EP2392645A1
(en)
|
2005-10-14 |
2011-12-07 |
MUSC Foundation For Research Development |
Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
|
|
US8080534B2
(en)
*
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
|
EP2560001B1
(en)
|
2006-09-21 |
2016-04-13 |
University of Rochester |
Compositions and methods related to protein displacement therapy for myotonic distrophy
|
|
US8999317B2
(en)
|
2006-11-01 |
2015-04-07 |
University Of Rochester |
Methods and compositions related to the structure and function of APOBEC3G
|
|
BRPI0720038A2
(pt)
|
2006-12-11 |
2013-12-24 |
Univ Utah Res Found |
Métodos para inibir a permeabilidade vascular em tecido, para triar ou avaliar um agente que inibe a permeabilidade vascular, para tratar ou prevenir a síndrome da angústia respiratória, a retinopatia de prematuridade, a retinopatia diabética e a degeneração macular úmida em um indivíduo, para tratar indivíduos com sugestões repulsivas ou miméticos e para promover a angiogênese em um tecido, polipeptídeo isolado, ácido nucleico isolado, e, vetor
|
|
EP2030615A3
(en)
*
|
2007-08-13 |
2009-12-02 |
ELFORD, Howard L. |
Ribonucleotide reductase inhibitors for use in the treatment or prevention of neuroinflammatory or autoimmune diseases
|
|
WO2009032702A2
(en)
|
2007-08-28 |
2009-03-12 |
Uab Research Foundation |
Synthetic apolipoprotein e mimicking polypeptides and methods of use
|
|
EP2195331B1
(en)
|
2007-08-28 |
2013-11-20 |
Uab Research Foundation |
Synthetic apolipoprotein e mimicking polypeptides and methods of use
|
|
WO2010070380A2
(en)
|
2007-12-03 |
2010-06-24 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health |
Doc1 compositions and methods for treating cancer
|
|
US20110262395A1
(en)
|
2008-05-08 |
2011-10-27 |
University Of Utah Research Foundation |
Sensory receptors for chronic fatigue and pain and uses thereof
|
|
WO2010019963A2
(en)
*
|
2008-08-15 |
2010-02-18 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
US20120070443A1
(en)
|
2008-12-02 |
2012-03-22 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
WO2011031974A1
(en)
|
2009-09-10 |
2011-03-17 |
Southern Research Institute |
Acridine analogs in the treatment of gliomas
|
|
US20110207789A1
(en)
|
2010-02-19 |
2011-08-25 |
Ye Fang |
Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents
|
|
SMT202000031T1
(it)
|
2010-06-09 |
2020-03-13 |
Genmab As |
Anticorpi contro cd38 umano
|
|
WO2014093688A1
(en)
|
2012-12-12 |
2014-06-19 |
1Massachusetts Institute Of Technology |
Compositions and methods for functional nucleic acid delivery
|
|
EP3071590A4
(en)
|
2013-11-21 |
2017-07-19 |
SeNA Research, Inc. |
Methods for structural determination of selenium derivatized nucleic acid complexes
|
|
CA2940111C
(en)
|
2014-02-21 |
2022-03-15 |
Ventana Medical Systems, Inc. |
Single-stranded oligonucleotide probes for chromosome or gene copy enumeration
|
|
WO2016018665A1
(en)
|
2014-07-31 |
2016-02-04 |
Uab Research Foundation |
Apoe mimetic peptides and higher potency to clear plasma cholesterol
|
|
US20170015699A1
(en)
*
|
2015-07-15 |
2017-01-19 |
Orizhan Bioscience Limited |
Partially Neutral Single-Stranded Oligonucleotide
|
|
EP3491014B1
(en)
|
2016-07-28 |
2023-04-05 |
Regeneron Pharmaceuticals, Inc. |
Allele-specific primer or probe hybridized to a nucleic acid molecule encoding a gpr156 variant
|
|
CN110087665A
(zh)
|
2016-08-03 |
2019-08-02 |
H·李·莫菲特癌症中心与研究所公司 |
Tlr9靶向治疗
|
|
RU2019126483A
(ru)
|
2017-01-23 |
2021-02-24 |
Ридженерон Фармасьютикалз, Инк. |
Варианты 17-бета-гидроксистероиддегидрогеназы 13 (hsd17b13) и их применение
|
|
US10738284B2
(en)
|
2017-06-05 |
2020-08-11 |
Regeneron Pharmaceuticals, Inc. |
B4GALT1 cDNA variants and compositions comprising the same
|
|
MX2020002643A
(es)
|
2017-09-06 |
2020-09-25 |
Regeneron Pharma |
Variantes relacionadas con el receptor de inmunoglobulina interleucina 1 simple (sigirr) y usos de estas.
|
|
CN111278851A
(zh)
|
2017-09-07 |
2020-06-12 |
雷杰纳荣制药公司 |
溶质运载体家族14成员1(slc14a1)变体及其用途
|
|
US12016314B2
(en)
|
2017-09-08 |
2024-06-25 |
Ohio State Innovation Foundation |
MicroRNA inhibitor therapy in systemic lupus erythematosus
|
|
AU2018348195B2
(en)
|
2017-10-11 |
2025-05-15 |
Regeneron Pharmaceuticals, Inc. |
Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
|
|
AU2018352234A1
(en)
|
2017-10-16 |
2020-04-23 |
Regeneron Pharmaceuticals, Inc. |
Cornulin (CRNN) variants and uses thereof
|
|
SG11202102255VA
(en)
*
|
2018-09-05 |
2021-04-29 |
Readcoor Llc |
Methods and systems for therapeutic agent analysis
|
|
WO2020076976A1
(en)
|
2018-10-10 |
2020-04-16 |
Readcoor, Inc. |
Three-dimensional spatial molecular indexing
|
|
US11957687B2
(en)
|
2019-07-02 |
2024-04-16 |
Regeneron Pharmaceuticals, Inc. |
Modulators of HSD17B13 and methods of use thereof
|
|
EP4097251A1
(en)
|
2020-01-29 |
2022-12-07 |
10X Genomics, Inc. |
Compositions and methods for analyte detection
|
|
US20220049303A1
(en)
|
2020-08-17 |
2022-02-17 |
Readcoor, Llc |
Methods and systems for spatial mapping of genetic variants
|
|
WO2024173343A1
(en)
|
2023-02-14 |
2024-08-22 |
Regeneron Pharmaceuticals, Inc. |
Compounds targeting hydroxysteroid 17-beta dehydrogenase (hsd17b) and uses thereof
|